Consistently, GABPA depletion significantly inhibits the response of ccRCC cells to TGFβ treatment, which includes diminished SMAD2/3 phosphorylation and increased MYC expression, while reduced CDKN1A expression. This evidence concerns the gene TGFB1 and nonpapillary renal cell carcinoma.